Trials / Unknown
UnknownNCT02975219
Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis
Determine the Feasibility of Detecting Endometriosis During Surgery Using a Molecular Targeted Fluorescent Imaging Tracer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Incomplete resection of endometriosis lesions often results in recurrence of symptoms and the need for repeated surgery, with considerable associated morbidity. The aim of this pilot project is to determine the feasibility of fluorescence imaging to improve the treatment of endometriosis in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab-800CW | 4.5mg Bevacizumab-800CW will be administered intravenously three days prior to surgery |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2016-11-29
- Last updated
- 2017-06-27
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02975219. Inclusion in this directory is not an endorsement.